Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial

Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio...

Full description

Saved in:
Bibliographic Details
Published inClinical nutrition (Edinburgh, Scotland) Vol. 40; no. 5; pp. 2527 - 2534
Main Authors Vázquez-Manjarrez, Natalia, Guevara-Cruz, Martha, Flores-López, Adriana, Pichardo-Ontiveros, Edgar, Tovar, Armando R., Torres, Nimbe
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2021
Subjects
Online AccessGet full text
ISSN0261-5614
1532-1983
1532-1983
DOI10.1016/j.clnu.2021.02.048

Cover

Abstract Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR). Sixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP. Subjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (−18.05%, P = 0.003) and TC (−17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL. Based on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk. Registered under ClinicalTrials.gov Identifier no. NCT04148976.
AbstractList Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR). Sixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP. Subjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (−18.05%, P = 0.003) and TC (−17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL. Based on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk. Registered under ClinicalTrials.gov Identifier no. NCT04148976.
Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR).Sixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP.Subjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (−18.05%, P = 0.003) and TC (−17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL.Based on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk.Registered under ClinicalTrials.gov Identifier no. NCT04148976.
Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR). Sixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP. Subjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (-18.05%, P = 0.003) and TC (-17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL. Based on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk. Registered under ClinicalTrials.gov Identifier no. NCT04148976.
Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR).BACKGROUND & AIMSCardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events, and is highly prevalent in the Mexican population. The primary objective of the present work was to assess the effect of a dietary portfolio (DP) with functional foods containing dehydrated nopal, soy protein, chia seeds, inulin, and oats in LDL-C and TC concentrations of subjects with mild hypercholesterolemia. Also, we explored the changes in the profile of the lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy (NMR).Sixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP.METHODSSixty-two subjects (47 women, 15 men) with mild hypercholesterolemia (LDL-C, ≥130 ≤ 190 mg/dL, TC > 200 mg/dL) completed the randomized, parallel, controlled study. The dietary intervention was given in two stages. First, a dietary standardization stage with a low saturated fat diet (LSFD) which matched the habitual energy intake of the volunteers for 2-weeks, followed by 2.5 months of dietary intervention with a LSFD plus placebo (PL) or DP.Subjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (-18.05%, P = 0.003) and TC (-17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL.RESULTSSubjects who consumed the LSFD + DP interventions had a significantly higher reduction of LDL-C (-18.05%, P = 0.003) and TC (-17.08%, P = 0.02) compared to volunteers who consumed an LSFD for the same period. Furthermore, the lipoprotein subclass profiling showed that the small low-density-lipoproteins, and the small high-density-lipoproteins significantly decreased (P = 0.04, P < 0.001, respectively), conveying a less atherogenic state. At the end of the study, 78% of the subjects who consumed LSFD + DP reduced their LDL-C below 160 mg/dL, and of these, 47% reduced it below 130 mg/dL.Based on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk. Registered under ClinicalTrials.gov Identifier no. NCT04148976.CONCLUSIONSBased on the results obtained from this study, the inclusion of functional foods as part of the lifestyle modifications is recommended to treat mild hypercholesterolemia and reduce cardiovascular risk. Registered under ClinicalTrials.gov Identifier no. NCT04148976.
Author Pichardo-Ontiveros, Edgar
Torres, Nimbe
Vázquez-Manjarrez, Natalia
Guevara-Cruz, Martha
Tovar, Armando R.
Flores-López, Adriana
Author_xml – sequence: 1
  givenname: Natalia
  surname: Vázquez-Manjarrez
  fullname: Vázquez-Manjarrez, Natalia
– sequence: 2
  givenname: Martha
  orcidid: 0000-0002-8996-3481
  surname: Guevara-Cruz
  fullname: Guevara-Cruz, Martha
– sequence: 3
  givenname: Adriana
  surname: Flores-López
  fullname: Flores-López, Adriana
– sequence: 4
  givenname: Edgar
  surname: Pichardo-Ontiveros
  fullname: Pichardo-Ontiveros, Edgar
– sequence: 5
  givenname: Armando R.
  orcidid: 0000-0002-1292-1312
  surname: Tovar
  fullname: Tovar, Armando R.
– sequence: 6
  givenname: Nimbe
  surname: Torres
  fullname: Torres, Nimbe
  email: nimbe.torrest@incmnsz.mx
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33932799$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1vEzEQtVARTQt_gAPykcsutne9u664oLR8SJGQEJwtxzsmDo4dbG-q_DT-Hd6mvfRQOI2see_N-M27QGc-eEDoNSU1JbR7t62181PNCKM1YTVph2doQXnDKiqG5gwtCOtoxTvanqOLlLaEEN70wwt03jSiYb0QC_TnxhjQGQeDFR4tZBWP2PoM8QA-2-Dxrc0bbCav55dy2IQwJlwaq-tVtcQ6eF2QUc3thJUfsbP7sI8hg_U4TWvtVEqQiioOB4i3YH9u8tzYlsHppL857iHqTXCQyuhSdlZd4W-QJlcgd8uVQbl0HIw4R6vcS_TcKJfg1X29RD8-3nxffq5WXz99WX5YVbptSa7GUbSsY7AmneDacCB6GKHTXU-bpjcK1pS2gzCGD70hQmkGuuNEdYJ0WhneXKK3J93ypd9T2U_ubNLgnPIQpiQZZy0TbTH0f6Bk4ITxWfXNPXRa72CU-2h3xXr5cJkCGE4AHUNKEYzUNt-ZXLy2TlIi5xDIrZxDIOcQSMJkCUGhskfUB_UnSe9PJCheHixEmbSFctvRxnInOQb7NP3qEV07661W7hcc_0X-C0VB47A
CitedBy_id crossref_primary_10_1016_j_ctim_2024_103086
crossref_primary_10_34172_jhp_2022_09
crossref_primary_10_1021_acsfoodscitech_3c00138
crossref_primary_10_1016_j_jff_2023_105867
crossref_primary_10_1097_HCO_0000000000000960
Cites_doi 10.1139/H08-023
10.1161/01.cir.0000437738.63853.7a
10.1001/jama.2016.13985
10.1002/mnfr.202000532
10.1007/BF02877717
10.1155/2017/1273042
10.1016/j.nutres.2009.09.013
10.1016/S0002-8223(02)90388-3
10.1016/S0026-0495(99)90184-1
10.5114/aoms.2017.69326
10.1038/s41598-017-05096-4
10.3390/ijms161126029
10.1093/ajcn.81.2.380
10.1016/j.jand.2014.06.352
10.1080/09168451.2015.1034650
10.1017/S000711451600341X
10.1111/jfbc.12539
10.1038/sj.ejcn.1602816
10.1001/jama.290.4.531
10.1161/JAHA.119.012401
10.1016/j.cll.2006.07.006
10.1016/j.diabet.2018.09.004
10.1039/C7FO00178A
10.1007/s00726-012-1276-0
10.1161/circ.106.25.3143
10.1038/sj.ejcn.1602347
10.2147/VHRM.S1653
10.1016/S0167-5273(99)00107-2
10.1161/CIRCULATIONAHA.108.816181
10.7326/0003-4819-158-7-201304020-00004
10.1016/j.atherosclerosis.2018.08.027
10.1186/1475-2891-6-6
10.1007/s11883-007-0067-7
10.1590/S0036-36342010000700008
10.3389/fnut.2019.00171
10.1007/s00394-004-0478-y
10.18553/jmcp.2016.22.6.685
10.1080/07315724.2017.1412275
ContentType Journal Article
Copyright 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism
Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Copyright_xml – notice: 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism
– notice: Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
DBID AAYXX
CITATION
NPM
7X8
7S9
L.6
DOI 10.1016/j.clnu.2021.02.048
DatabaseName CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA
PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1532-1983
EndPage 2534
ExternalDocumentID 33932799
10_1016_j_clnu_2021_02_048
S0261561421001382
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACJTP
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADHUB
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXBA
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
E.L
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LZ1
M29
M2W
M41
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SEL
SES
SEW
SNG
SNH
SPCBC
SSH
SSZ
T5K
UAP
UHS
UV1
WUQ
Z5R
ZGI
~G-
AACTN
AAIAV
AAQFI
ABLVK
ABYKQ
AFCTW
AFKWA
AISVY
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
NAHTW
RIG
AAYXX
ACLOT
CITATION
~HD
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-c440t-dd94262eb0695cf5e0c8de6c671337faeb11489ff587f09ac2ec650a6906caf53
IEDL.DBID .~1
ISSN 0261-5614
1532-1983
IngestDate Sun Sep 28 02:24:46 EDT 2025
Sun Sep 28 02:39:29 EDT 2025
Thu Apr 03 06:55:07 EDT 2025
Wed Oct 01 01:40:20 EDT 2025
Thu Apr 24 23:11:17 EDT 2025
Fri Feb 23 02:47:28 EST 2024
Tue Aug 26 17:17:43 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Lipoproteins
Hypercholesterolemia
Soy-protein
Cardiovascular-risk
Oats
Nopal
Language English
License Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c440t-dd94262eb0695cf5e0c8de6c671337faeb11489ff587f09ac2ec650a6906caf53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1292-1312
0000-0002-8996-3481
PMID 33932799
PQID 2520850255
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2524294932
proquest_miscellaneous_2520850255
pubmed_primary_33932799
crossref_citationtrail_10_1016_j_clnu_2021_02_048
crossref_primary_10_1016_j_clnu_2021_02_048
elsevier_sciencedirect_doi_10_1016_j_clnu_2021_02_048
elsevier_clinicalkey_doi_10_1016_j_clnu_2021_02_048
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical nutrition (Edinburgh, Scotland)
PublicationTitleAlternate Clin Nutr
PublicationYear 2021
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Lammi, Zanoni, Arnoldi (bib30) 2015; 16
Jeyarajah, Cromwell, Otvos (bib12) 2006; 26
Jenkins, Josse, Wong, Nguyen, Kendall (bib8) 2007; 9
Global Health Estimates 2016 (bib1) 2018
Izadi, Haghighatdoost, Moosavian, Azadbakht (bib23) 2018; 37
Guevara-Cruz, Tovar, Aguilar-Salinas, Medina-Vera, Gil-Zenteno, Hernández-Viveros (bib15) 2012; 142
Guevara-Cruz, Flores-López, Aguilar-López, Sánchez-Tapia, Medina-Vera, Díaz (bib9) 2019; 8
Ivanova, Myasoedova, Melnichenko, Grechko, Orekhov (bib46) 2017; 2017
Medina-Vera, Sanchez-Tapia, Noriega-López, Granados-Portillo, Guevara-Cruz, Flores-López (bib10) 2019; 45
Anderson (bib22) 2003; 290
Pak, Koo, Kwon, Yun (bib29) 2012; 43
Muñoz-Hernandez, Ortiz-Bautista, Brito-Córdova, Lozano-Arvizu, Saucedo, Pérez-Méndez (bib4) 2018; 277
Zhang, Plutzky, Skentzos, Morrison, Mar, Shubina (bib19) 2013; 158
Inoue, Fujiwara, Kato, Funayama, Ogawa, Tachibana (bib31) 2015; 79
Torres, Guevara-Cruz, Granados, Vargas-Alarcón, González-Palacios, Ramos-Barragan (bib17) 2009; 29
Chatterjee, Gleddie, Xiao (bib28) 2018; vol. 10
Linares, Thimonier, Degre (bib39) 2007; 24
Packard, Caslake, Shepherd (bib45) 2000; 74
Lin, Sung, Sanchez, Mallya, Friedman, Panaccio (bib21) 2016; 22
Lovati, Manzoni, Gianazza, Arnoldi, Kurowska, Carroll (bib26) 2000; 130
Jenkins, Kendall, Marchie, Faulkner, Wong, de Souza (bib43) 2005; 81
Third Report of the National Cholesterol Education Program (Ncep) Expert Panel on Detection (bib2) 2002; 106
López-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vázquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, et al. The effect of nopal ( Opuntia Ficus indica ) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. Journal of the Academy of Nutrition and Dietetics.114:1811-1818.
Aguilar-Salinas, Gomez-Perez, Rull, Villalpando, Barquera, Rojas (bib6) 2010; 52
Cicero, Colletti, Bajraktari, Descamps, Djuric, Ezhov (bib25) 2017; 5
Ascencio, Torres, Isoard-Acosta, Gómez-Pérez, Hernández-Pando (bib32) 2004; 134
Nilsson, Johansson, Nilsson, Björck, Nyman (bib38) 2008; 62
Kapur, Musunuru (bib42) 2008; 4
Yoshida, Vanstone, Parsons, Zawistowski, Jones (bib24) 2006; 60
Cicero, Fogacci, Colletti (bib33) 2017; 8
Insp (bib7) 2016
Sánchez-Tapia, Moreno-Vicencio, Ordáz-Nava, Guevara-Cruz, Granados-Portillo, Vargas-Castillo (bib34) 2020; 64
Mora, Otvos, Rifai, Rosenson, Buring, Ridker (bib3) 2009; 119
Jenkins, Kendall, Mehling, Parker, Rao, Agarwal (bib16) 1999; 48
Toth, Statins (bib20) 2019; vol. 15
Joyce, Kamil, Fleige, Gahan (bib36) 2019; 6
Stone, Robinson, Lichtenstein, Merz, Blum, Eckel (bib18) 2014; 129
Cicero, Fiorito, Panourgia, Sangiorgi, Gaddi (bib13) 2002; 102
Santo, Cunningham, Alhassan, Browne, Burton, Leddy (bib5) 2008; 33
Ho, Sievenpiper, Zurbau, Blanco Mejia, Jovanovski, Au-Yeung (bib35) 2016; 116
Lohman (bib11) 1940
Cicero, Minardi, Mirembe, Pedro, Gaddi (bib14) 2004; 43
Queenan, Stewart, Smith, Thomas, Fulcher, Slavin (bib37) 2007; 6
Silverman, Ference, Im, Wiviott, Giugliano, Grundy (bib44) 2016; 316
Sánchez-Tapia, Aguilar-López, Pérez-Cruz, Pichardo-Ontiveros, Wang, Donovan (bib40) 2017; 7
Nagaoka (bib27) 2019; 43
Lohman (10.1016/j.clnu.2021.02.048_bib11) 1940
Pak (10.1016/j.clnu.2021.02.048_bib29) 2012; 43
Ascencio (10.1016/j.clnu.2021.02.048_bib32) 2004; 134
Queenan (10.1016/j.clnu.2021.02.048_bib37) 2007; 6
Guevara-Cruz (10.1016/j.clnu.2021.02.048_bib9) 2019; 8
Torres (10.1016/j.clnu.2021.02.048_bib17) 2009; 29
Lovati (10.1016/j.clnu.2021.02.048_bib26) 2000; 130
Kapur (10.1016/j.clnu.2021.02.048_bib42) 2008; 4
Chatterjee (10.1016/j.clnu.2021.02.048_bib28) 2018; vol. 10
Sánchez-Tapia (10.1016/j.clnu.2021.02.048_bib40) 2017; 7
Ivanova (10.1016/j.clnu.2021.02.048_bib46) 2017; 2017
Cicero (10.1016/j.clnu.2021.02.048_bib14) 2004; 43
10.1016/j.clnu.2021.02.048_bib41
Anderson (10.1016/j.clnu.2021.02.048_bib22) 2003; 290
Jenkins (10.1016/j.clnu.2021.02.048_bib43) 2005; 81
Jeyarajah (10.1016/j.clnu.2021.02.048_bib12) 2006; 26
Izadi (10.1016/j.clnu.2021.02.048_bib23) 2018; 37
Toth (10.1016/j.clnu.2021.02.048_bib20) 2019; vol. 15
Sánchez-Tapia (10.1016/j.clnu.2021.02.048_bib34) 2020; 64
Cicero (10.1016/j.clnu.2021.02.048_bib33) 2017; 8
Santo (10.1016/j.clnu.2021.02.048_bib5) 2008; 33
Nilsson (10.1016/j.clnu.2021.02.048_bib38) 2008; 62
Lin (10.1016/j.clnu.2021.02.048_bib21) 2016; 22
Nagaoka (10.1016/j.clnu.2021.02.048_bib27) 2019; 43
Insp (10.1016/j.clnu.2021.02.048_bib7) 2016
Mora (10.1016/j.clnu.2021.02.048_bib3) 2009; 119
Jenkins (10.1016/j.clnu.2021.02.048_bib8) 2007; 9
Guevara-Cruz (10.1016/j.clnu.2021.02.048_bib15) 2012; 142
Cicero (10.1016/j.clnu.2021.02.048_bib25) 2017; 5
Zhang (10.1016/j.clnu.2021.02.048_bib19) 2013; 158
Yoshida (10.1016/j.clnu.2021.02.048_bib24) 2006; 60
Silverman (10.1016/j.clnu.2021.02.048_bib44) 2016; 316
Third Report of the National Cholesterol Education Program (Ncep) Expert Panel on Detection (10.1016/j.clnu.2021.02.048_bib2) 2002; 106
Linares (10.1016/j.clnu.2021.02.048_bib39) 2007; 24
Aguilar-Salinas (10.1016/j.clnu.2021.02.048_bib6) 2010; 52
Lammi (10.1016/j.clnu.2021.02.048_bib30) 2015; 16
Joyce (10.1016/j.clnu.2021.02.048_bib36) 2019; 6
Ho (10.1016/j.clnu.2021.02.048_bib35) 2016; 116
Inoue (10.1016/j.clnu.2021.02.048_bib31) 2015; 79
Muñoz-Hernandez (10.1016/j.clnu.2021.02.048_bib4) 2018; 277
Cicero (10.1016/j.clnu.2021.02.048_bib13) 2002; 102
Global Health Estimates 2016 (10.1016/j.clnu.2021.02.048_bib1) 2018
Medina-Vera (10.1016/j.clnu.2021.02.048_bib10) 2019; 45
Jenkins (10.1016/j.clnu.2021.02.048_bib16) 1999; 48
Stone (10.1016/j.clnu.2021.02.048_bib18) 2014; 129
Packard (10.1016/j.clnu.2021.02.048_bib45) 2000; 74
References_xml – volume: 52
  start-page: S44
  year: 2010
  end-page: S53
  ident: bib6
  article-title: Prevalence of dyslipidemias in the Mexican national health and nutrition Survey 2006
  publication-title: Salud Publica Mex
– volume: 29
  start-page: 728
  year: 2009
  end-page: 735
  ident: bib17
  article-title: Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects
  publication-title: Nutr Res
– volume: 16
  start-page: 27362
  year: 2015
  end-page: 27370
  ident: bib30
  article-title: Three peptides from soy glycinin modulate glucose metabolism in human hepatic HepG2 cells
  publication-title: Int J Mol Sci
– volume: 43
  start-page: 2015
  year: 2012
  end-page: 2025
  ident: bib29
  article-title: Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase
  publication-title: Amino Acids
– volume: 26
  start-page: 847
  year: 2006
  end-page: 870
  ident: bib12
  article-title: Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
  publication-title: Clin Lab Med
– volume: 33
  start-page: 489
  year: 2008
  end-page: 500
  ident: bib5
  article-title: NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile
  publication-title: Appl Physiol Nutr Metabol
– volume: 316
  start-page: 1289
  year: 2016
  end-page: 1297
  ident: bib44
  article-title: Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis
  publication-title: J Am Med Assoc
– volume: vol. 15
  start-page: 23
  year: 2019
  end-page: 31
  ident: bib20
  article-title: Then and now. Methodist debakey cardiovasc J
– year: 1940
  ident: bib11
  article-title: Anthropometric standardization reference manual
– volume: vol. 10
  start-page: 1211
  year: 2018
  ident: bib28
  article-title: Soybean bioactive peptides and their functional properties. Nutrients
– volume: 79
  start-page: 1528
  year: 2015
  end-page: 1534
  ident: bib31
  article-title: Soybean β-conglycinin improves carbohydrate and lipid metabolism in Wistar rats
  publication-title: Biosc Biotech Biochem
– volume: 43
  start-page: 319
  year: 2004
  end-page: 322
  ident: bib14
  article-title: Effects of a new low dose soy protein/β-sitosterol association on plasma lipid levels and oxidation
  publication-title: Eur J Nutr
– volume: 129
  start-page: S1
  year: 2014
  end-page: S45
  ident: bib18
  article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults
  publication-title: Circulation
– volume: 64
  start-page: 2000532
  year: 2020
  ident: bib34
  article-title: Antibiotic treatment reduces the health benefits of soy protein
  publication-title: Mol Nutr Food Res
– volume: 158
  start-page: 526
  year: 2013
  end-page: 534
  ident: bib19
  article-title: Discontinuation of statins in routine care settings: a cohort study
  publication-title: Ann Intern Med
– volume: 43
  start-page: e12539
  year: 2019
  ident: bib27
  article-title: Structure–function properties of hypolipidemic peptides
  publication-title: J Food Biochem
– volume: 4
  start-page: 341
  year: 2008
  end-page: 353
  ident: bib42
  article-title: Clinical efficacy and safety of statins in managing cardiovascular risk
  publication-title: Vasc Health Risk Manag
– volume: 74
  start-page: S17
  year: 2000
  end-page: S22
  ident: bib45
  article-title: The role of small, dense low density lipoprotein (LDL): a new look
  publication-title: Int J Cardiol
– year: 2018
  ident: bib1
  article-title: Disease burden by cause, age, sex, by country and by region, 2000-2016
– volume: 119
  start-page: 931
  year: 2009
  end-page: 939
  ident: bib3
  article-title: Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
  publication-title: Circulation
– volume: 24
  start-page: 111d5
  year: 2007
  end-page: 1125
  ident: bib39
  article-title: The effect of NeOpuntia on blood lipid parameters–risk factors for the metabolic syndrome (syndrome X)
  publication-title: Adv Ther
– volume: 5
  start-page: 965
  year: 2017
  end-page: 1005
  ident: bib25
  article-title: Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
  publication-title: Arch Med Sci
– volume: 102
  start-page: 1807
  year: 2002
  end-page: 1811
  ident: bib13
  article-title: Effects of a new soy/β-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects
  publication-title: J Am Diet Assoc
– start-page: 1
  year: 2016
  end-page: 154
  ident: bib7
  article-title: Encuesta nacional de Salud y Nutrición de Medio camino
– volume: 130
  start-page: 2543
  year: 2000
  end-page: 2549
  ident: bib26
  article-title: Soy protein peptides regulate cholesterol homeostasis in hep G2 cells
  publication-title: J Nutr
– volume: 37
  start-page: 399
  year: 2018
  end-page: 405
  ident: bib23
  article-title: Effect of low-energy-dense diet rich in multiple functional foods on weight-loss maintenance, inflammation, and cardiovascular risk factors: a randomized controlled trial
  publication-title: J Am Coll Nutr
– volume: 106
  start-page: 3143
  year: 2002
  end-page: 3421
  ident: bib2
  article-title: Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report
  publication-title: Circulation
– volume: 2017
  start-page: 1273042
  year: 2017
  ident: bib46
  article-title: Small dense low-density lipoprotein as biomarker for atherosclerotic diseases
  publication-title: Oxid Med Cell Longev
– volume: 8
  start-page: e012401
  year: 2019
  end-page: e
  ident: bib9
  article-title: Improvement of lipoprotein profile and metabolic endotoxemia by a lifestyle intervention that modifies the gut microbiota in subjects with metabolic syndrome
  publication-title: J Am Heart Assoc.
– volume: 290
  start-page: 531
  year: 2003
  end-page: 533
  ident: bib22
  article-title: Diet first, then medication for hypercholesterolemia
  publication-title: J Am Med Assoc
– volume: 48
  start-page: 809
  year: 1999
  end-page: 816
  ident: bib16
  article-title: Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterol-lowering diet
  publication-title: Metab, Clin Exp
– reference: López-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vázquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, et al. The effect of nopal (<em>Opuntia Ficus indica</em>) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. Journal of the Academy of Nutrition and Dietetics.114:1811-1818.
– volume: 45
  start-page: 122
  year: 2019
  end-page: 131
  ident: bib10
  article-title: A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes
  publication-title: Diabetes Metabol
– volume: 134
  start-page: 522
  year: 2004
  end-page: 529
  ident: bib32
  article-title: Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats
  publication-title: J Nutr
– volume: 9
  start-page: 501
  year: 2007
  end-page: 507
  ident: bib8
  article-title: The portfolio diet for cardiovascular risk reduction
  publication-title: Curr Atherosclerosis Rep
– volume: 142
  start-page: 64
  year: 2012
  end-page: 69
  ident: bib15
  article-title: A dietary pattern including nopal, chia seed, soy protein, and oat reduces serum triglycerides and glucose intolerance in patients with metabolic syndrome
  publication-title: J Nutr
– volume: 22
  start-page: 685
  year: 2016
  end-page: 698
  ident: bib21
  article-title: Patterns of statin use in a real-world population of patients at high cardiovascular risk
  publication-title: Journal of Managed Care & Specialty Pharmacy
– volume: 8
  start-page: 2076
  year: 2017
  end-page: 2088
  ident: bib33
  article-title: Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach
  publication-title: Food & Function
– volume: 62
  start-page: 978
  year: 2008
  end-page: 984
  ident: bib38
  article-title: Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects
  publication-title: Eur J Clin Nutr
– volume: 116
  start-page: 1369
  year: 2016
  end-page: 1382
  ident: bib35
  article-title: The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials
  publication-title: Br J Nutr
– volume: 6
  start-page: 171
  year: 2019
  ident: bib36
  article-title: The cholesterol-lowering effect of oats and oat beta glucan: modes of action and potential role of bile acids and the microbiome
  publication-title: Frontiers in Nutrition
– volume: 81
  start-page: 380
  year: 2005
  end-page: 387
  ident: bib43
  article-title: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants
  publication-title: Am J Clin Nutr
– volume: 6
  start-page: 6
  year: 2007
  ident: bib37
  article-title: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial
  publication-title: Nutr J
– volume: 60
  start-page: 529
  year: 2006
  end-page: 537
  ident: bib24
  article-title: Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes
  publication-title: Eur J Clin Nutr
– volume: 7
  start-page: 4716
  year: 2017
  ident: bib40
  article-title: Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet
  publication-title: Sci Rep
– volume: 277
  start-page: 72
  year: 2018
  end-page: 79
  ident: bib4
  article-title: Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
  publication-title: Atherosclerosis
– volume: 130
  start-page: 2543
  year: 2000
  ident: 10.1016/j.clnu.2021.02.048_bib26
  article-title: Soy protein peptides regulate cholesterol homeostasis in hep G2 cells
  publication-title: J Nutr
– volume: 33
  start-page: 489
  year: 2008
  ident: 10.1016/j.clnu.2021.02.048_bib5
  article-title: NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile
  publication-title: Appl Physiol Nutr Metabol
  doi: 10.1139/H08-023
– volume: 129
  start-page: S1
  year: 2014
  ident: 10.1016/j.clnu.2021.02.048_bib18
  article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults
  publication-title: Circulation
  doi: 10.1161/01.cir.0000437738.63853.7a
– volume: 316
  start-page: 1289
  year: 2016
  ident: 10.1016/j.clnu.2021.02.048_bib44
  article-title: Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.2016.13985
– volume: 64
  start-page: 2000532
  year: 2020
  ident: 10.1016/j.clnu.2021.02.048_bib34
  article-title: Antibiotic treatment reduces the health benefits of soy protein
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.202000532
– volume: 24
  start-page: 111d5
  year: 2007
  ident: 10.1016/j.clnu.2021.02.048_bib39
  article-title: The effect of NeOpuntia on blood lipid parameters–risk factors for the metabolic syndrome (syndrome X)
  publication-title: Adv Ther
  doi: 10.1007/BF02877717
– volume: 2017
  start-page: 1273042
  year: 2017
  ident: 10.1016/j.clnu.2021.02.048_bib46
  article-title: Small dense low-density lipoprotein as biomarker for atherosclerotic diseases
  publication-title: Oxid Med Cell Longev
  doi: 10.1155/2017/1273042
– volume: vol. 10
  start-page: 1211
  year: 2018
  ident: 10.1016/j.clnu.2021.02.048_bib28
– volume: 134
  start-page: 522
  year: 2004
  ident: 10.1016/j.clnu.2021.02.048_bib32
  article-title: Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats
  publication-title: J Nutr
– volume: 29
  start-page: 728
  year: 2009
  ident: 10.1016/j.clnu.2021.02.048_bib17
  article-title: Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2009.09.013
– year: 1940
  ident: 10.1016/j.clnu.2021.02.048_bib11
– volume: 102
  start-page: 1807
  year: 2002
  ident: 10.1016/j.clnu.2021.02.048_bib13
  article-title: Effects of a new soy/β-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects
  publication-title: J Am Diet Assoc
  doi: 10.1016/S0002-8223(02)90388-3
– volume: 48
  start-page: 809
  year: 1999
  ident: 10.1016/j.clnu.2021.02.048_bib16
  article-title: Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterol-lowering diet
  publication-title: Metab, Clin Exp
  doi: 10.1016/S0026-0495(99)90184-1
– volume: 5
  start-page: 965
  year: 2017
  ident: 10.1016/j.clnu.2021.02.048_bib25
  article-title: Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
  publication-title: Arch Med Sci
  doi: 10.5114/aoms.2017.69326
– volume: 7
  start-page: 4716
  year: 2017
  ident: 10.1016/j.clnu.2021.02.048_bib40
  article-title: Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-05096-4
– volume: 16
  start-page: 27362
  year: 2015
  ident: 10.1016/j.clnu.2021.02.048_bib30
  article-title: Three peptides from soy glycinin modulate glucose metabolism in human hepatic HepG2 cells
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms161126029
– volume: 81
  start-page: 380
  year: 2005
  ident: 10.1016/j.clnu.2021.02.048_bib43
  article-title: Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn.81.2.380
– ident: 10.1016/j.clnu.2021.02.048_bib41
  doi: 10.1016/j.jand.2014.06.352
– volume: 79
  start-page: 1528
  year: 2015
  ident: 10.1016/j.clnu.2021.02.048_bib31
  article-title: Soybean β-conglycinin improves carbohydrate and lipid metabolism in Wistar rats
  publication-title: Biosc Biotech Biochem
  doi: 10.1080/09168451.2015.1034650
– volume: 116
  start-page: 1369
  year: 2016
  ident: 10.1016/j.clnu.2021.02.048_bib35
  article-title: The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials
  publication-title: Br J Nutr
  doi: 10.1017/S000711451600341X
– volume: 43
  start-page: e12539
  year: 2019
  ident: 10.1016/j.clnu.2021.02.048_bib27
  article-title: Structure–function properties of hypolipidemic peptides
  publication-title: J Food Biochem
  doi: 10.1111/jfbc.12539
– volume: 62
  start-page: 978
  year: 2008
  ident: 10.1016/j.clnu.2021.02.048_bib38
  article-title: Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects
  publication-title: Eur J Clin Nutr
  doi: 10.1038/sj.ejcn.1602816
– volume: 290
  start-page: 531
  year: 2003
  ident: 10.1016/j.clnu.2021.02.048_bib22
  article-title: Diet first, then medication for hypercholesterolemia
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.290.4.531
– volume: 8
  start-page: e012401
  year: 2019
  ident: 10.1016/j.clnu.2021.02.048_bib9
  article-title: Improvement of lipoprotein profile and metabolic endotoxemia by a lifestyle intervention that modifies the gut microbiota in subjects with metabolic syndrome
  publication-title: J Am Heart Assoc.
  doi: 10.1161/JAHA.119.012401
– volume: 26
  start-page: 847
  year: 2006
  ident: 10.1016/j.clnu.2021.02.048_bib12
  article-title: Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
  publication-title: Clin Lab Med
  doi: 10.1016/j.cll.2006.07.006
– year: 2018
  ident: 10.1016/j.clnu.2021.02.048_bib1
– volume: 45
  start-page: 122
  year: 2019
  ident: 10.1016/j.clnu.2021.02.048_bib10
  article-title: A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes
  publication-title: Diabetes Metabol
  doi: 10.1016/j.diabet.2018.09.004
– volume: 8
  start-page: 2076
  year: 2017
  ident: 10.1016/j.clnu.2021.02.048_bib33
  article-title: Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach
  publication-title: Food & Function
  doi: 10.1039/C7FO00178A
– volume: 43
  start-page: 2015
  year: 2012
  ident: 10.1016/j.clnu.2021.02.048_bib29
  article-title: Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase
  publication-title: Amino Acids
  doi: 10.1007/s00726-012-1276-0
– volume: 106
  start-page: 3143
  year: 2002
  ident: 10.1016/j.clnu.2021.02.048_bib2
  article-title: Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 60
  start-page: 529
  year: 2006
  ident: 10.1016/j.clnu.2021.02.048_bib24
  article-title: Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes
  publication-title: Eur J Clin Nutr
  doi: 10.1038/sj.ejcn.1602347
– volume: vol. 15
  start-page: 23
  year: 2019
  ident: 10.1016/j.clnu.2021.02.048_bib20
– volume: 4
  start-page: 341
  year: 2008
  ident: 10.1016/j.clnu.2021.02.048_bib42
  article-title: Clinical efficacy and safety of statins in managing cardiovascular risk
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/VHRM.S1653
– volume: 74
  start-page: S17
  year: 2000
  ident: 10.1016/j.clnu.2021.02.048_bib45
  article-title: The role of small, dense low density lipoprotein (LDL): a new look
  publication-title: Int J Cardiol
  doi: 10.1016/S0167-5273(99)00107-2
– volume: 142
  start-page: 64
  year: 2012
  ident: 10.1016/j.clnu.2021.02.048_bib15
  article-title: A dietary pattern including nopal, chia seed, soy protein, and oat reduces serum triglycerides and glucose intolerance in patients with metabolic syndrome
  publication-title: J Nutr
– volume: 119
  start-page: 931
  year: 2009
  ident: 10.1016/j.clnu.2021.02.048_bib3
  article-title: Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.816181
– volume: 158
  start-page: 526
  year: 2013
  ident: 10.1016/j.clnu.2021.02.048_bib19
  article-title: Discontinuation of statins in routine care settings: a cohort study
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-158-7-201304020-00004
– start-page: 1
  year: 2016
  ident: 10.1016/j.clnu.2021.02.048_bib7
– volume: 277
  start-page: 72
  year: 2018
  ident: 10.1016/j.clnu.2021.02.048_bib4
  article-title: Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.08.027
– volume: 6
  start-page: 6
  year: 2007
  ident: 10.1016/j.clnu.2021.02.048_bib37
  article-title: Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial
  publication-title: Nutr J
  doi: 10.1186/1475-2891-6-6
– volume: 9
  start-page: 501
  year: 2007
  ident: 10.1016/j.clnu.2021.02.048_bib8
  article-title: The portfolio diet for cardiovascular risk reduction
  publication-title: Curr Atherosclerosis Rep
  doi: 10.1007/s11883-007-0067-7
– volume: 52
  start-page: S44
  issue: Suppl 1
  year: 2010
  ident: 10.1016/j.clnu.2021.02.048_bib6
  article-title: Prevalence of dyslipidemias in the Mexican national health and nutrition Survey 2006
  publication-title: Salud Publica Mex
  doi: 10.1590/S0036-36342010000700008
– volume: 6
  start-page: 171
  year: 2019
  ident: 10.1016/j.clnu.2021.02.048_bib36
  article-title: The cholesterol-lowering effect of oats and oat beta glucan: modes of action and potential role of bile acids and the microbiome
  publication-title: Frontiers in Nutrition
  doi: 10.3389/fnut.2019.00171
– volume: 43
  start-page: 319
  year: 2004
  ident: 10.1016/j.clnu.2021.02.048_bib14
  article-title: Effects of a new low dose soy protein/β-sitosterol association on plasma lipid levels and oxidation
  publication-title: Eur J Nutr
  doi: 10.1007/s00394-004-0478-y
– volume: 22
  start-page: 685
  year: 2016
  ident: 10.1016/j.clnu.2021.02.048_bib21
  article-title: Patterns of statin use in a real-world population of patients at high cardiovascular risk
  publication-title: Journal of Managed Care & Specialty Pharmacy
  doi: 10.18553/jmcp.2016.22.6.685
– volume: 37
  start-page: 399
  year: 2018
  ident: 10.1016/j.clnu.2021.02.048_bib23
  article-title: Effect of low-energy-dense diet rich in multiple functional foods on weight-loss maintenance, inflammation, and cardiovascular risk factors: a randomized controlled trial
  publication-title: J Am Coll Nutr
  doi: 10.1080/07315724.2017.1412275
SSID ssj0005378
Score 2.355909
Snippet Cardiovascular diseases (CVDs) are the leading cause of global death. Hypercholesterolemia is among the main risk factors for developing cardiovascular events,...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2527
SubjectTerms Cardiovascular-risk
clinical nutrition
death
energy intake
Hypercholesterolemia
inulin
lifestyle
Lipoproteins
Nopal
nuclear magnetic resonance spectroscopy
nutritional intervention
Oats
Opuntia
overweight
placebos
population
risk
Salvia hispanica
Soy-protein
standardization
Title Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0261561421001382
https://dx.doi.org/10.1016/j.clnu.2021.02.048
https://www.ncbi.nlm.nih.gov/pubmed/33932799
https://www.proquest.com/docview/2520850255
https://www.proquest.com/docview/2524294932
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1532-1983
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005378
  issn: 0261-5614
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1532-1983
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005378
  issn: 0261-5614
  databaseCode: ACRLP
  dateStart: 19950201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1532-1983
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005378
  issn: 0261-5614
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Freedom Collection Journals
  customDbUrl:
  eissn: 1532-1983
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005378
  issn: 0261-5614
  databaseCode: AIKHN
  dateStart: 19950201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1532-1983
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005378
  issn: 0261-5614
  databaseCode: AKRWK
  dateStart: 19820101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi4S4IFhe5bEaJMQFhbaJ8zC3VZdVgd0egJX2FjnOWASFpGqaAxf-F_-OmdipFgmKxClK7LGceDIvj78R4kWJMk1R6iBNrAqkLLKAuASDEOeYhSmasODQwMUqWV7K91fx1YFYjGdhOK3Sy34n0wdp7Z9M_decrqtq-om9B8axDOfDdhvLYUb_Ip5-_eNamkfkpDHHWbi3PzjjcrxM3fTkI4YOt5NrAP1ZOf3N-ByU0Nkdcdtbj3DiJnhXHGBzJCanFW7hJXiIzxpWI8L-kbh54ffO74mfDqgYWgsaSiLRm-9QXUt5BI7JAis6Fx8E27ZlB9RwfnoeLMDwCcfGw-x2oJsS6mrdDkgPVQNdXxg2xbGjUaEdEq7Z8-cGDvZ0bvwv5PhuWOYOEA10-VbpN_ARu76mLsPkfPp8jSUMRUXui8uzt58Xy8AXbgiMlLNtUJaKge6xmCUqNjbGmclKTEzCHnFqNekH8sKUtXGW2pnSJkRDlqJm0GSjbRw9EIdN2-AjASrLEhqGzTZLehTV3MRa6TBGaVQmi4mYjyuWG49qzsU16nxMX_ua8yrnvMr5LMxplSfi1Y5m7TA99vaORkbIx9OqJF9zUjl7qeId1W_8_E-65yOv5fSj8-6NbrDtuzyMuZwqu4B7-5B9Ickmn4iHjlF3bxhF9DhV6vF_zuyJuMV3LtnzqTjcbnp8RgbZtjge_rhjcePk3Yfl6hdztzir
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLemTgIuCMZXx5eREBcUNU3sJOY2dUwda3uATdrNchxbCwpJ1TSH_Wn8d7wXOwUkKBKnSLaf5cQv78vPv0fI28KwNDVMBWliRcBYngXAJSaIzNRkUWp0lGNoYLlK5lfs0zW_PiCz4S4MplV62e9kei-tfcvEf83JuiwnX9B7QBzLaNoft4EcPmQcZPKIHJ6cX8xXPzM9YieQMdSCBP7ujEvz0lXdgZsYOehOLAP0Z_30N_uz10NnD8h9b0DSE7fGh-TA1EdkfFqaLX1HPcpnRVcDyP4RubP0x-ePyHeHVUwbSxUtgERtbmn5S9YjxbAsRV3nQoTUNk3RUuhYnC6CGdV4ybH2SLstVXVBq3Ld9GAPZU3bLtdojZsWZqVNn3ONzj92YLyndfPfgO-7QbHbozTA41upPtDPpu0qGNIvzmfQV6agfV2Rx-Tq7OPlbB742g2BZizcBkUhEOve5GEiuLbchDorTKITdIpTq0BFgCMmrOVZakOhdGQ0GIsKcZO1sjx-QkZ1U5tnhIosS2AatNwsqFIjpporoSJumBYZy8dkOuyY1B7YHOtrVHLIYPsqcZcl7rIMIwm7PCbvdzRrB-uxd3Q8MIIcLqyCiJWgdfZS8R3Vbyz9T7o3A69J-NfxAEfVpulaGXGsqIpe4N4xYGIwMMvH5Klj1N0bxjE0p0Ic_-fKXpO788vlQi7OVxfPyT3scbmfL8hou-nMS7DPtvkr___9AO28O1Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+a+dietary+intervention+with+functional+foods+on+LDL-C+concentrations+and+lipoprotein+subclasses+in+overweight+subjects+with+hypercholesterolemia%3A+Results+of+a+controlled+trial&rft.jtitle=Clinical+nutrition+%28Edinburgh%2C+Scotland%29&rft.au=V%C3%A1zquez-Manjarrez%2C+Natalia&rft.au=Guevara-Cruz%2C+Martha&rft.au=Flores-L%C3%B3pez%2C+Adriana&rft.au=Pichardo-Ontiveros%2C+Edgar&rft.date=2021-05-01&rft.issn=0261-5614&rft.volume=40&rft.issue=5+p.2527-2534&rft.spage=2527&rft.epage=2534&rft_id=info:doi/10.1016%2Fj.clnu.2021.02.048&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0261-5614&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0261-5614&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0261-5614&client=summon